Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome

BACKGROUND: Adiponectin acts as an antidiabetic, antiinflammatory and antiatherogenic adipokine. These effects are assumed to be mediated by the recently discovered adiponectin receptors AdipoR1 and AdipoR2. AIM: The purpose of this study was to determine whether variations in the AdipoR1 and AdipoR...

Descripción completa

Detalles Bibliográficos
Autores principales: Broedl, Uli C, Lehrke, Michael, Fleischer-Brielmaier, Elisabeth, Tietz, Anne B, Nagel, Jutta M, Göke, Burkhard, Lohse, Peter, Parhofer, Klaus G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482678/
https://www.ncbi.nlm.nih.gov/pubmed/16700915
http://dx.doi.org/10.1186/1475-2840-5-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482678/
https://www.ncbi.nlm.nih.gov/pubmed/16700915
http://dx.doi.org/10.1186/1475-2840-5-11

Ejemplares similares